Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein.
Wrobel, A.G., Benton, D.J., Hussain, S., Harvey, R., Martin, S.R., Roustan, C., Rosenthal, P.B., Skehel, J.J., Gamblin, S.J.(2020) Nat Commun 11: 5337-5337
- PubMed: 33087721 
- DOI: https://doi.org/10.1038/s41467-020-19146-5
- Primary Citation of Related Structures:  
7A5R, 7A5S - PubMed Abstract: 
The CR3022 antibody, selected from a group of SARS-CoV monoclonal antibodies for its ability to cross-react with SARS-CoV-2, has been examined for its ability to bind to the ectodomain of the SARS-CoV-2 spike glycoprotein. Using cryo-electron microscopy we show that antibody binding requires rearrangements in the S1 domain that result in dissociation of the spike.
Organizational Affiliation: 
Structural Biology of Disease Processes Laboratory, Francis Crick Institute, NW1 1AT, London, UK. antoni.wrobel@crick.ac.uk.